title: Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?
authors.affiliation: Sandoz Ltd. Preclinical Research, Basel, Switzerland.
authors.forename: D
authors.initials: D
authors.lastname: Hoyer
authors.forename: H
authors.initials: H
authors.lastname: Gozlan
authors.forename: F
authors.initials: F
authors.lastname: Bolanos
authors.forename: L E
authors.initials: LE
authors.lastname: Schechter
authors.forename: M
authors.initials: M
authors.lastname: Hamon
mesh_terms: D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D007211:Indoles / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism; D011619:Psychotropic Drugs / Q000494:pharmacology*; D051381:Rats; D011985:Receptors, Serotonin / Q000187:drug effects*; D012702:Serotonin Antagonists / Q000494:pharmacology; D000077526:Tropisetron; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
chemical_list: D007211:Indoles; D011619:Psychotropic Drugs; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D000077526:Tropisetron